Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,688 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 541 of 641 · 7,688 filings

  • Realty Income (O) FY2024 10-K risk factors
    33 risks

    Real estate acquisition competition and debt leveraging dominate the risk profile.

    Filed Feb 25, 2025
  • Old Dominion Freight Line (ODFL) FY2024 10-K risk factors
    40 risks

    OOLD DOMINION FREIGHT LINE, INC. faces primary operational risks from equipment supply constraints, fuel cost volatility, and driver labor pressures. The company navigates intense LTL industry competition, stringent EPA and CARB emissions regulations, and significant capital expenditure requirements.

    Filed Feb 25, 2025
  • Orthofix Medical (OFIX) FY2024 10-K risk factors
    61 risks

    Integration of the SeaSpine business drives major operational, financial, and management complexities for the company.

    Filed Feb 25, 2025
  • Oneok (OKE) FY2024 10-K risk factors
    41 risks

    This filing has no prior year. Its risk profile is dominated by commodity price volatility, pipeline operational hazards, and integration risks from recent acquisitions like EnLink and Medallion.

    Filed Feb 25, 2025
  • ONTO Innovation (ONTO) FY2024 10-K risk factors
    46 risks

    Onto Innovation faces significant customer concentration and competition in the semiconductor capital equipment market.

    Filed Feb 25, 2025
  • Offerpad Solutions (OPAD) FY2024 10-K risk factors
    80 risks

    High sensitivity to U.S. residential real estate health and mortgage interest rate volatility, particularly across 26 metropolitan markets. Accumulated deficit reached $460.0 million as of December 31, 2024, amid competitive pressures and inventory pricing risks.

    Filed Feb 25, 2025
  • Vaxcyte (PCVX) FY2024 10-K risk factors
    71 risks

    Vaxcyte has no commercial products and relies entirely on clinical-stage vaccine candidates like VAX-31 and VAX-24. The company holds $3,134.7 billion in cash, cash equivalents, and investments as of December 31, 2024. Operations depend heavily on a cell-free manufacturing platform and third-party contract manufacturers like Lonza.

    Filed Feb 25, 2025
  • Public Service Enterprise Group (PEG) FY2024 10-K risk factors
    39 risks

    Capital spending depends on regulatory approvals, cost recovery, and successful construction of T&D, clean-energy, and nuclear projects.

    Filed Feb 25, 2025
  • Palomar Holdings (PLMR) FY2024 10-K risk factors
    60 risks

    Palomar Holdings is highly exposed to catastrophic loss activity and regulatory environments concentrated in California.

    Filed Feb 25, 2025
  • Planet Fitness (PLNT) FY2024 10-K risk factors
    51 risks

    Planet Fitness relies on brand value, franchise expansion, and electronic fund transfers, facing risks from high industry competition and rising construction costs.

    Filed Feb 25, 2025
  • Douglas Dynamics (PLOW) FY2024 10-K risk factors
    29 risks

    Demand depends heavily on weather and general economic conditions in the snow-belt regions. Raw material price volatility, specifically steel, significantly impacts gross margins. Relationships with independent distributors and truck equipment OEMs are critical to operations. Substantial debt and variable interest rates expose the company to financial risk.

    Filed Feb 25, 2025
  • Pentair (PNR) FY2024 10-K risk factors
    37 risks

    Pentair faces material customer concentration with its largest customer representing approximately 15 percent of net sales in 2024. The company carries $4,320.4 million in goodwill and intangible assets representing 67 percent of total assets. Total debt stands at $1,663.1 million as of December 31, 2024.

    Filed Feb 25, 2025

Companies covered

4,011 companies

371 more under A